Literature DB >> 19747564

Individual domains of Tensin2 exhibit distinct subcellular localisations and migratory effects.

Sassan Hafizi1, Emma Sernstad, Jerome D Swinny, Maria F Gomez, Björn Dahlbäck.   

Abstract

Tensins are large intracellular proteins believed to link the extracellular matrix to the cytoskeleton via integrins. Tensins are multidomain proteins consisting of homologous C1, PTPase, C2, SH2 and PTB domains. Full-length Tensin proteins can undergo cleavage inside cells, thus yielding domains in isolation that may have discrete subcellular localisations and downstream effects. We expressed different isoforms of Tensin2 and their individual domains as recombinant green fluorescent protein (GFP)-fusion constructs in DU145 human prostate cancer cells. Under fluorescence confocal microscopy, the isolated domains of Tensin2 all displayed discrete distributions throughout the cytoplasm and the nucleus. In particular, partial constructs containing the C1 domain localised preferentially to the nucleus, including the isolated C1 domain and the PTPase domain. In contrast, all three full-length isoforms of Tensin2 were present exclusively in discrete punctate bodies throughout the cytoplasm. This punctate staining showed colocalisation with the tumour suppressor protein DLC-1 as well as with actin (phalloidin). Furthermore, DU145 cells transiently expressing partial Tensin2 constructs containing the PTB domain showed an increased haptotactic migration. In addition, stimulation of renal carcinoma cells stably expressing Tensin2 by the survival factor Gas6 caused phosphorylation of its receptor Axl, but no effect on Tensin2, which was already maximally phosphorylated at time 0. In conclusion, our results indicate that differential proteolytic cleavage of Tensin2 can liberate domains with discrete localisations and functions, which has implications for the role of Tensins in cancer cell survival and motility.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747564     DOI: 10.1016/j.biocel.2009.09.005

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  9 in total

1.  Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.

Authors:  Lihong Chen; Changdong Liu; Frankie Chi Fat Ko; Naining Xu; Irene Oi-Lin Ng; Judy Wai Ping Yam; Guang Zhu
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

2.  The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2.

Authors:  Kyung D Moon; Xiaoying Zhang; Qing Zhou; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2011-10-12

3.  CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.

Authors:  Jessica A Carter; Dariusz C Górecki; Charles A Mein; Börje Ljungberg; Sassan Hafizi
Journal:  Epigenetics       Date:  2013-05-24       Impact factor: 4.528

4.  Interaction of DISC1 with the PTB domain of Tensin2.

Authors:  Salman Goudarzi; Luke J M Smith; Steffen Schütz; Sassan Hafizi
Journal:  Cell Mol Life Sci       Date:  2012-12-12       Impact factor: 9.261

5.  Functional characterisation of human cells harbouring a novel t(2p;7p) translocation involving TNS3 and EXOC6B genes.

Authors:  Desiree Ludwig; Jessica Carter; James R Smith; Giuseppe Borsani; Sergio Barlati; Sassan Hafizi
Journal:  BMC Med Genet       Date:  2013-06-28       Impact factor: 2.103

6.  Mouse chromosome 2 harbors genetic determinants of resistance to podocyte injury and renal tubulointerstitial fibrosis.

Authors:  Hayato Sasaki; Junpei Kimura; Ken-Ichi Nagasaki; Kiyoma Marusugi; Takashi Agui; Nobuya Sasaki
Journal:  BMC Genet       Date:  2016-05-26       Impact factor: 2.797

7.  AXL phosphorylates and up-regulates TNS2 and its implications in IRS-1-associated metabolism in cancer cells.

Authors:  Li-Chun Cheng; Yen-Lin Chen; An-Ning Cheng; Alan Yueh-Luen Lee; Chun-Yu Cho; Jhy-Shrian Huang; Shuang-En Chuang
Journal:  J Biomed Sci       Date:  2018-11-12       Impact factor: 8.410

Review 8.  Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).

Authors:  Drazen B Zimonjic; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2012-05-10       Impact factor: 5.650

9.  Down-regulation of tensin2 enhances tumorigenicity and is associated with a variety of cancers.

Authors:  Shiao-Ya Hong; Yi-Ping Shih; Peng Sun; Wang-Ju Hsieh; Wen-Chang Lin; Su Hao Lo
Journal:  Oncotarget       Date:  2016-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.